Lincoln Pharmaceuticals announced a final dividend of ₹1.80 per share for FY26, reporting a net profit of ₹11.63 crore in Q4FY26. The company aims for ₹1,000 crore revenue in three years, focusing on expanding its product portfolio and global presence.
Market Samachar is a news aggregator. This article was originally published by mint - markets. Tap the button above to read the full story on their site.